Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
New England Journal of Medicine
Payers
Study warns drug companies not to delay cancer drug launches
Despite pharma companies' recent threats in response to new drug price negotiation program rules, analysis found there is little financial upside.
Noah Tong
Oct 7, 2023 7:20am
Healthcare experts warn about growing risk of nuclear war
Aug 1, 2023 6:00pm
North Carolina Blues touts success of food-as-medicine program
Mar 20, 2023 4:50pm
COVID-19 made preprint studies important
Jan 27, 2023 12:54pm
Quarter of hospital admissions had adverse event in 2018: study
Jan 19, 2023 9:00am
New bill aims to reform CMS' drug coverage authority
Dec 1, 2022 7:05am
